Northwestern Mutual Wealth Management CO Xeris Biopharma Holdings, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $147 Billion
- Q3 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 7,789 shares of XERS stock, worth $56,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,789
Previous 2,789
179.28%
Holding current value
$56,470
Previous $13,000
384.62%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
235Shares Held
94.5MCall Options Held
251KPut Options Held
61.8K-
Vanguard Group Inc Valley Forge, PA11.2MShares$81.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...